en

PRODUCT DETAIL

Imatinib Sandoz 100 mg

Code 4131C
MA number 44/0495/15-S
Product Form: tbl flm 50x100 mg (blis.PVC/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EA BCR-ABL tyrosine kinase inhibitors
L01EA01 Imatinib
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 09.12.2015
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Imatinib Sandoz 100 mg_03.2023.pdf  
PIL: PIL_Imatinib Sandoz 100 mg_03.2023.pdf  
Safety feature Yes
Data update: 09.03.2023
eu-flag.png sk-flag.png